Literature DB >> 21733691

Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.

Thushara Diyabalanage1, Ranjala Ratnayake, Jennifer A Wilson, Curtis J Henrich, John A Beutler, Nancy H Colburn, James B McMahon, Kirk R Gustafson.   

Abstract

A high throughput screen for inhibitors of the oncogenic transcription factor activator protein-1 (AP-1) was applied to the NCI repository of natural product extracts. The liphophilic extract of the plant Nothospondias staudtii (Simaroubaceae) displayed significant AP-1 inhibition. Bioassay-guided fractionation of the extract lead to a new quassinoid named nothospondin (1), and the known compound glaucarubinone (2). The structure of 1 was elucidated by spectroscopic methods. Compounds 1 and 2 showed potent, dose-dependent AP-1 inhibition at noncytotoxic concentrations. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733691      PMCID: PMC4671370          DOI: 10.1016/j.bmcl.2011.06.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.

Authors:  Yoshihide Usami; Kyoko Nakagawa-Goto; Jing-Yu Lang; Yoon Kim; Chin-Yu Lai; Masuo Goto; Nobuko Sakurai; Masahiko Taniguchi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kenneth F Bastow; Gordon Cragg; David J Newman; Mihoyo Fujitake; Koichi Takeya; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

2.  A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1.

Authors:  Katie M Ruocco; Ekaterina I Goncharova; Matthew R Young; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2006-12-14

3.  Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.

Authors:  M R Young; J J Li; M Rincón; R A Flavell; B K Sathyanarayana; R Hunziker; N Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

4.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Authors:  Z Dong; M J Birrer; R G Watts; L M Matrisian; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 5.  The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

Authors:  I B Weinstein
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

6.  Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.

Authors:  Matthew R Young; Linda Farrell; Paul Lambert; Parirokh Awasthi; Nancy H Colburn
Journal:  Mol Carcinog       Date:  2002-06       Impact factor: 4.784

Review 7.  AP-1 a target for cancer prevention.

Authors:  Connie P Matthews; Nancy H Colburn; Matthew R Young
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

8.  Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.

Authors:  John A Beutler; Moon-Il Kang; Francis Robert; Jason A Clement; Jerry Pelletier; Nancy H Colburn; Tawnya C McKee; Ekaterina Goncharova; James B McMahon; Curtis J Henrich
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

9.  High throughput extraction of plant, marine and fungal specimens for preservation of biologically active molecules.

Authors:  Thomas G McCloud
Journal:  Molecules       Date:  2010-06-24       Impact factor: 4.411

  9 in total
  1 in total

1.  Small molecule inhibitors targeting activator protein 1 (AP-1).

Authors:  Na Ye; Ye Ding; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2014-05-27       Impact factor: 8.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.